UBS Group’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-168,059
| Closed | -$1.88M | – | 7240 |
|
|
2017
Q3 | $1.88M | Buy |
168,059
+7,104
| +4% | +$79.6K | ﹤0.01% | 2542 |
|
|
2017
Q2 | $1.77M | Buy |
160,955
+160,879
| +211,683% | +$1.77M | ﹤0.01% | 2504 |
|
|
2017
Q1 | $0 | Sell |
76
-2,284
| -97% | – | ﹤0.01% | 7056 |
|
|
2016
Q4 | $26K | Buy |
2,360
+961
| +69% | +$10.6K | ﹤0.01% | 5424 |
|
|
2016
Q3 | $14K | Buy |
1,399
+239
| +21% | +$2.39K | ﹤0.01% | 5674 |
|
|
2016
Q2 | $15K | Sell |
1,160
-4,858
| -81% | -$62.8K | ﹤0.01% | 5660 |
|
|
2016
Q1 | $66K | Buy |
6,018
+3,273
| +119% | +$35.9K | ﹤0.01% | 4508 |
|
|
2015
Q4 | $25K | Buy |
2,745
+34
| +1% | +$310 | ﹤0.01% | 5379 |
|
|
2015
Q3 | $19K | Sell |
2,711
-4,389
| -62% | -$30.8K | ﹤0.01% | 5508 |
|
|
2015
Q2 | $70K | Sell |
7,100
-8,637
| -55% | -$85.2K | ﹤0.01% | 4546 |
|
|
2015
Q1 | $140K | Buy |
15,737
+8,506
| +118% | +$75.7K | ﹤0.01% | 4004 |
|
|
2014
Q4 | $64K | Buy |
+7,231
| New | +$64K | ﹤0.01% | 4532 |
|